↓ Skip to main content

Cochrane Database of Systematic Reviews

Bisphosphonates and other bone agents for breast cancer

Overview of attention for article published in this source, February 2012
Altmetric Badge

Mentioned by

policy
1 policy source
twitter
6 X users
facebook
1 Facebook page

Citations

dimensions_citation
197 Dimensions

Readers on

mendeley
178 Mendeley
Title
Bisphosphonates and other bone agents for breast cancer
Published by
John Wiley & Sons, Ltd, February 2012
DOI 10.1002/14651858.cd003474.pub3
Pubmed ID
Authors

Wong, Matthew HF, Stockler, Martin R, Pavlakis, Nick

Abstract

Bone is the most common site of metastatic disease associated with breast cancer (BC). Bisphosphonates inhibit osteoclast-mediated bone resorption, and novel targeted therapies such as denosumab, inhibit key pathways in the vicious cycle of bone metastases.

Timeline
X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 178 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 1%
Spain 1 <1%
France 1 <1%
Canada 1 <1%
Unknown 173 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 33 19%
Student > Master 25 14%
Student > Ph. D. Student 20 11%
Other 18 10%
Student > Bachelor 16 9%
Other 30 17%
Unknown 36 20%
Readers by discipline Count As %
Medicine and Dentistry 91 51%
Agricultural and Biological Sciences 8 4%
Nursing and Health Professions 8 4%
Psychology 5 3%
Biochemistry, Genetics and Molecular Biology 3 2%
Other 13 7%
Unknown 50 28%